Rna replicons, compositions and methods of use thereof
AssigneeAble Sciences, Inc.
InventorsJolly M. CHENDRIMADA, Thimmaiah CHENDRIMADA
Life of this patent
Estimating the term…
Loading patent…
AssigneeAble Sciences, Inc.
InventorsJolly M. CHENDRIMADA, Thimmaiah CHENDRIMADA
Estimating the term…
The present disclosure provides novel self-amplifying RNA (saRNA) constructs engineered for enhanced protein expression, prolonged durability, reduced immunogenicity, and homogeneous expression of multiple therapeutic proteins. The saRNA constructs comprise a 5′ untranslated region, non-structural protein genes derived from alphaviruses, at least one gene of interest encoding a therapeutic protein, a 3′ untranslated region, and modified nucleosides. Also disclosed are dual construct systems and multivalent polycistronic constructs with flexible, modular component arrangements, including bivalent through hexavalent embodiments encoding combinations of chimeric antigen receptors (CARs), cytokine-anchored chimeric antigen receptors (CCARs), cytokines, cytokine muteins, immune checkpoint inhibitors, and co-stimulatory molecules. Methods of producing and using the saRNA constructs for engineering immune cells for treatment of cancer, inflammatory conditions, and infectious diseases are provided.
A self-amplifying RNA (saRNA) construct comprising a 5′ untranslated region (5′UTR), non-structural protein (NSP) genes encoding an RNA-dependent RNA polymerase complex, at least one subgenomic promoter operably linked to at least one gene of interest encoding a therapeutic protein, and a 3′ untranslated region (3′UTR), wherein the NSP genes comprise one or more modifications to enhance protein expression, increase durability, or reduce immunogenicity.
Dependencies are inferred from the claim text.